NGC Update Service: March 5, 2018

March 5, 2018

New This Week

Announcements

Last Call for Guidelines

Funding to support AHRQ's NGC contract ends on July 16, 2018. To allow time for summaries and NEATS assessments to be posted to the NGC Web site by July 2018, guidelines will no longer be accepted for inclusion after March 5, 2018. Additional information will be posted when AHRQ can announce next steps for NGC. In the meantime, contact Mary.Nix@ahrq.hhs.gov.

G-I-N Conference

The Guidelines International Network (G-I-N) 2018 Conference will take place from September 11-14, 2018 in Manchester. The theme is "Why We Do What We Do: The Purpose and Impact of Guidelines." Registration is open. For more information, visit the G-I-N Conference Web site.

U.S. Food and Drug Administration (FDA) Advisory

February 22, 2018: Clarithromycin (Biaxin): FDA is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later. FDAs recommendation is based on a review of the results of a 10-year follow-up study of patients with coronary heart disease from a large clinical trial that first observed this safety issue.

Health Awareness Topics: March 2018

• Bleeding Disorders Awareness Month (see related guidelines)
• National Colorectal Cancer Awareness Month (see related guidelines)
• National Endometriosis Awareness Month (see related guidelines)
• National Kidney Month (see related guidelines)
• National Nutrition Month® (see related guidelines)

NGC's Sister Resource

Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).